Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Head Neck. 2023 May 19;45(8):1903–1912. doi: 10.1002/hed.27402

Table 2.

Odds ratios for major postoperative outcomes by NLR group

Outcome Prevalence, % Odds Ratio 95% CI
General Postoperative Outcomes
 Death within 30 days 1.0 2.12* 1.42–3.16
 1 or more VASQIP complications 13.3 1.39* 1.22–1.58
 Return to OR within 30 days 13.2 1.07 0.94–1.23
Cardiac Postoperative Outcomes
 Cardiac arrest requiring CPR 0.5 1.25 0.68–2.30
 Myocardial infarction 0.3 0.68 0.28–1.62
Central Nervous System Postoperative Outcomes
 Coma lasting >24 hours post-op 0.1 1.15 0.30–4.48
 Cerebral vascular accident/Stroke 0.3 1.29 0.61–2.73
Other Surgical Postoperative Outcomes
 Bleeding requiring >4 units pRBCs 0.2 1.72 0.75–3.94
 Deep vein thrombosis/Thrombophlebitis§ 0.3 1.09 0.49–2.39
 Sepsis 1.3 1.51* 1.05–2.17
Respiratory Postoperative Outcomes
 Failure to wean off mechanical ventilation >48 hours 2.9 1.30* 1.01–1.68
 Pneumonia 3.5 1.58* 1.26–1.99
 Pulmonary embolism 0.3 2.51* 1.17–5.37
 Reintubation for respiratory/cardiac failure 2.1 1.25 0.92–1.70
Urinary Tract Postoperative Outcomes
 Acute renal failure post-op 0.1 0.76 0.18–3.23
 Progressive renal insufficiency 0.2 1.20 0.50–2.88
 Urinary tract infection 1.1 1.14 0.75–1.73
Wound Postoperative Outcomes
 Superficial surgical site infection 2.6 1.13 0.85–1.49
 Deep wound surgical site infection 1.2 1.42 0.96–2.09

Abbreviations: NLR, neutrophil-to-lymphocyte ratio; CI, confidence interval; OR, operating room; pRBCs, packed red blood cells

*

Statistically significant

Race recategorized as White, Black, or Other

No chemotherapy in model

§

No ASA classification in model

No race in model